Cantitate/Preț
Produs

Oncologic Critical Care

Editat de Joseph L. Nates, Kristen J. Price
en Limba Engleză Hardback – 30 oct 2019
This major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care. 

Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients.
Citește tot Restrânge

Preț: 816875 lei

Preț vechi: 859868 lei
-5% Nou

Puncte Express: 12253

Preț estimativ în valută:
156383 170459$ 131495£

Carte disponibilă

Livrare economică 26 noiembrie-10 decembrie
Livrare express 09-15 noiembrie pentru 24648 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319745879
ISBN-10: 3319745875
Pagini: 1200
Ilustrații: XLV, 2099 p. 225 illus., 145 illus. in color. In 3 volumes, not available separately.
Dimensiuni: 178 x 254 x 45 mm
Greutate: 5.55 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

Part 1. Organization and Management of an Oncologic Critical Care Unit

1. Oncologic Critical Care Department Organization 
2. Critical Care Staffing 
3. ICU Admission and Discharge Criteria 
4. Quality Assurance and Improvement 
5. ICU Utilization 
6. Current Trends in ICU Beds, Use, Occupancy, and Costs in the United States 
7. Early Warning Systems for the ICU
8. Patient Risk Prediction Model (Severity of Illness Scores) 

Part 2. Multidisciplinary Care 

9. Rapid Response Team 
10. Nursing
11. Pharmacy 
12. Nutrition 
13. Physical and Occupational Therapy
14. Patient Support
15. Advocacy and Social Work
16. Chaplaincy 

Part 3. Advance Practice Providers 

17. Role of the APPs in the Onco-ICU
18. Credentialing
19. Competencies

Part 4. Clinical Pharmacy 

20. Chemotherapy 
21. Considerations for Medications Commonly Utilized in the Oncology Population
22. Supportive Care Considerations

Part 5. Dermatologic Complications
 
23. GHVD, TEN, and Mycosis Fungoides 

Part 6. Neurologic Diseases 

24. Medication-induced Neurotoxicity 
25. Delirium and Psychosis 
26. Seizures and Status Epilepticus 
27. Stroke 
28. Increased Intracranial Pressure (brain mets, ich, hydrocephalus, etc) 
29. Posterior Reversible Encephalopathy Syndrome (PRES) 
30. Tumor-related Diseases/Neoplastic Meningitis/Leptomeningeal Disease   
31. Frequent CNS Infections in the Immunosuppressed Patient 
32. Intracranial Hemorrhage Focused on Cancer and Hemato-oncologic Patients
33. Spinal Cord Compression 
34. TCD in the ICU 

Part 7. Respiratory Diseases 

35. Acute and Chronic Respiratory Failure 
36. Oxygen therapy (low-flow and high-flow oxygen therapy) 
37. Respiratory Care of the Critically Ill Patient  
38. Management of Tracheobronchial Diseases 
39. Pulmonary Hypertension 
40. ARDS and the differential diagnosis of pulmonary infiltrates in the cancer patient
41. Diffuse Alveolar Hemorrhage 
42. Differentiation (Retinoic acid ATRA) Syndrome 
43. Late Non Infectious Pulmonary Complications in Hematopoietic Stem Cell Transplantation 
44. Treatment-related Lung Injury  
45. Pneumonia in the Cancer Patient 
46. Ventilatory Strategies and Weaning from Mechanical Ventilation 
47. Noninvasive Ventilation 
48. High Frequency Ventilation 
49. Prone Ventilatory Therapy 
50. Bi-Level and Airway Pressure Release Ventilation 
51. NAVA 
52. ECMO in Cancer Patients 
53. Tracheostomy: Appropriateness and Indications in Cancer Patients 
54. Pleural Disease, Malignant and Benign Pleural Effusions
55. Sleep Disorders in the Oncologic ICU 

Part 8. Cardiovascular Diseases

56. Hemodynamic evaluation
57. Acute Coronary Syndrome Thrombocytopenia and Antiplatelet Therapy in the Cancer Patient 
58. Interventional Cardiology in the Cancer Patient 
59. Arrhythmias in the Cancer Patient 
60. Management of Pericardial Effusions/Tamponade 
61. Chemotherapy-related Cardiovascular Complications 
62. Cardiopulmonary Resuscitation in the Cancer Patient 

Part 9. Gastrointestinal Disease 

63. Gastrointestinal Bleeding 
64. Malignant Ascites 
65. Hepatobiliary Disease
66. Acute abdomen in the cancer patient 

Part 10. Genitourinary Disease 

67. Hematuria
68. Hemorrhagic cystitis
69. Obstructive Uropathy in the Cancer Patient

Part 11. Renal Disease 

70. Acute Renal Failure
71. Renal Replacement Therapy 

Part 12. Metabolic/Endocrine Complications 

72. Adrenal Emergencies 
73. Carcinoid Crises 
74. Thyroid Emergencies  
75. Electrolytic Abnormalities 
76. Hypoglycemia and Hyperglycemia in the Cancer Patient 

Part 13. Hematologic Diseases 

77. Malignant Hematological Diseases
78. Benign Hematological Diseases  
79. Immunology and molecular biology for the intensivist 

Part 14. Transfusion Medicine 

80. Statistics 
81. Blood Products 
82. Transfusion Reactions 
83. Transfusion Related Lung Injury 
84. Alternatives to Blood Products
85. Massive Bleeding Protocol 
86. Transfusion Thresholds 

Part 15. Vascular Complications 

87. Management of Arterial Bleeding  
88. Prevention and Management of Venous Thromboembolism in the Cancer Patient 
89. SVC Syndrome 
90. Catheter-related Deep Vein Thrombosis 

Part 16. Infectious Diseases 

91. Infection Control Procedures 
92. Neutropenic Fever 
93. Sepsis and Management of Septic Shock  
94. Management of Multi-Drug Resistant Organisms 
95. Fungal Infections 
96. Viral Infections 
97. Bacterial and Atypical Infections 
98. Catheter and Device Related Infections 
99. Nosocomial Infections and Ventilator Associated Pneumonia 
100. Protozoal Infections in the Cancer Patients
101. Antibiotic Stewardship 
102. Tropical diseases in the cancer patient
103. Soft tissue infections 

Part 17. Post-Surgical Care of the Critically Ill Cancer Patient

104. Neurosurgery
105. Head & Neck Surgery 
106. Plastic Surgery & Flap Graft Management 
107. Thoracic Surgery 
108. GI Surgery 
109. Hepatic Surgery 
110. Pancreatic Surgery 
111. Genitourinary Surgery 
112. Orthopedic Surgery 
113. Interventional Radiology 
114. Radiation Therapy & Gamma Knife Procedures 
115. MRI 
116. Outpatient Surgery 

Part 18. Special Patient Populations 

117. Management of the Pregnant Critically Ill Cancer Patient 
118. Special Considerations of Hemato-Oncologic Critically Ill Patient 
119. Pediatric Cancer Critical Care 

Part 19. Critical Care Procedures 

120. ICU Procedures by APP 
121. Management of the Airway in the Cancer Patient 
122. Use of Ultrasound Guidance 
123. Interventional Radiology Procedures 

Part 20. Ethics 

124. Do Not Resuscitate Orders
125. Ethics Consultation
126. End of Life Care
127. Medical Futility

Part 21. Pain Management, Palliative Care, and Outcomes

128. Acute Pain 
129. Chronic Pain 
130. Substance Withdrawal 
131. Palliative Care in the critically ill cancer patient 
132. Outcomes in Critically Ill Oncologic Patients

Notă biografică

Dr. Joseph L. Nates is a Professor at the University of Texas MD Anderson Cancer Center. He has lived and practiced medicine in several countries. Currently, he is the Deputy Chair of the Department of Critical Care in the Division of Anesthesiology, Critical Care, and Pain Medicine. Dr. Nates is also the Medical Director of the 70-bed Oncologic Surgical and Medical Intensive Care Units and the Founder and President of the Oncologic Critical Care Research Network (ONCCC-R-NET), a global organization dedicated to the advancement of oncologic critical care research and education. Through his organization, Dr. Nates has been leading the pioneering efforts to establish Oncologic Critical Care as a new subspecialty and disseminate this knowledge worldwide. As the foundation for this objective, he has led and coauthored the first two comprehensive oncologic critical care textbooks, in both Spanish and English languages. He has also established regional and global collaborative networks and organized several Oncologic Critical Care symposiums.
Throughout his career, Dr. Nates has occupied multiple leadership positions and received numerous awards, among them the Presidential Award for “Outstanding Achievement and Leadership for Elimination of Ventilator-Associated Pneumonia” from the Department of Health and Human Services and the four leading Critical Care Societies in the USA in 2012, the “Bill Aston Award for Quality” from the Texas Hospital Association, and Distinguished Service Award in 2015, as well as many other research awards during his career. In 2018, for his contributions to critical care, the American College of Critical Care Medicine awarded him the title Master of Critical Care Medicine. The same year, for his international contributions to the development of Oncologic Critical Care, the Chilean Society of Critical Care and Emergency Medicine awarded him the title International Master of Critical Care Medicine.
Dr. Kristen J. Price was born and raised in New Orleans, Louisiana. She received her undergraduate degree in Marine Science from the University of Tampa followed by a Doctor of Medicine degree from Louisiana State University Medical Center in New Orleans. She completed an Internal Medicine residency, Chief Medical Residency, and Pulmonary and Critical Care fellowship at the University of Texas Health in Houston. Following training, she joined the faculty at the University of Texas MD Anderson Cancer Center and currently holds the title of Professor and Chair, Department of Critical Care and Respiratory Care. Under her leadership, the number of faculty and advance practice providers has grown substantially. She also oversees the Respiratory Care Department and the Section of Integrated Bioethics in Cancer Care. Dr. Price developed the multifaceted “Intensive Care Unit Organizational Infrastructure” to systematically organize, establish, and sustain evidence-based clinical, educational, and research initiatives in the ICU. Her main focus of research has been in the outcomes of critically ill oncology patients, particularly those with hematologic malignancies and respiratory failure. She is an active member of the Society of Critical Care Medicine and currently serves on the “Academic Leaders in Critical Care Medicine” task force. Dr. Price has four grown children and currently resides in Houston, Texas.

Caracteristici

The most comprehensive resources on oncologic critical care
Presented in an easy-to-navigate format for ease of use
Includes over 200 high-yield illustrations and photographs
Written by worldwide experts in the field
Includes supplementary material: sn.pub/extras